Nektar Therapeutics - Common Stock (NKTR) stock analysis
NKTR · Nektar Therapeutics - Common Stock
Latest recorded price: USD 36.44
Sector and industry: Healthcare · Biotechnology
Fiscal 2025 figures: revenue growth -15.7%, free cash flow margin -377.8%. The model flags 2 risk signals for this company (2 high severity).